OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

✍ Scribed by Diener, H.; Dodick, D.; Aurora, S.; Turkel, C.; DeGryse, R.; Lipton, R.; Silberstein, S.; Brin, M.

• Book ID: 121656167
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 243 KB
• Volume: 30
• Category: Article
• ISSN: 0333-1024
• DOI: 10.1177/0333102410364677